Study Title: A Phase 1 Open Label Study to Evaluate the Efficacy and Safety of ABBV-400 in Select Advanced Solid Tumor Indications
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Albert Lockhart, at lockhara@musc.edu.Study Coordinator, Holly Boggan, at bogganhl@musc.edu, or please call +1 843-792-8068.Trial opened at the following institutions: Medical University of South Carolina